T.Man Pharmaceutical Public Company LimitedSET: TMAN🇹🇭 TH
This company's most recent 56-1 One Report was filed as a PDF document (spec v3.0), so SET does not publish its section-by-section detail in a machine-readable form. Some information on this site is therefore incomplete.

Financial Information

Key Financial Highlights

As at 2026-09-30 · Unit: M.Baht

Item20242025H1 20269M 2026
Total revenue2,2262,6911,2281,947
Net profit450.7523.07212.21336.08
Total assets3,4563,7843,8703,786
Total liabilities1,6861,6671,6691,557
Shareholders' equity1,7702,1172,2012,229
EPS (Baht)1.311.310.530.84
ROE (%)27.426.9124.5924.87
ROA (%)18.0817.7417.0216.95
Net profit margin (%)20.2519.4417.2817.26
D/E (times)0.950.790.760.7
ItemY/E 2023Dec 2023Y/E 2024Dec 2024Y/E 2025Dec 20259M/2025Sep 20259M/2026Sep 2026
Cash And Cash Equivalents348.04448.39399.31392.02268.88
A/R Net616.54613.931,038.07918.91896.44
Inventories481.82541.45612.66676.09728.65
Current Assets1,451.382,074.092,405.52,240.782,251.48
PP&E Net1,048.111,143.251,204.121,154.561,277.04
Non-Current Assets1,175.871,381.571,378.211,521.981,534.13
Total Assets2,627.253,455.663,783.723,762.763,785.61
OD150.891,080875890820
A/P Net331.91370.1507.62682.03484.12
Current portion of LT33.08————
Current Liabilities1,022.41,576.11,553.31,714.091,418.07
Non-Current Liabilities85.45109.62113.41113.45138.47
Total Liabilities1,107.851,685.721,666.721,827.541,556.53
Authorized Capital300300300300300
Paid-Up Capital246.43300300300300
Premium (Discount) on Share Capital305.881,393.891,393.891,393.891,393.89
Retained Earnings (Deficit)993.46327.82674.88493.1786.96
Treasury Stock—————
Shares Of The Company Held By Subsidiaries—————
Other Components Of Equity-26.37-251.78-251.78-251.78-251.78
- Surplus (Deficits)-26.37-251.78-251.78-251.78-251.78
Shareholders' Equity1,519.391,769.932,1171,935.222,229.08
Minority Interest000—0

Auditor's Reports

ReportDate of submissionAuditor’s opinionAuditor’s firm
Q3 /202616 Nov 2026Unqualified opinionKPMG PHOOMCHAI AUDIT LIMITED
Q2 /202613 Aug 2026Unqualified opinionKPMG PHOOMCHAI AUDIT LIMITED
Q1 /202614 May 2026Unqualified opinionKPMG PHOOMCHAI AUDIT LIMITED
Yearly 202526 Feb 2026Unqualified opinionKPMG PHOOMCHAI AUDIT LIMITED
Q3 /202512 Nov 2025Unqualified opinionKPMG PHOOMCHAI AUDIT LIMITED